IFNA1 and rheumatoid arthritis: On the one hand, Smiljanovic and colleagues demonstrated that the IFN signature observed in RA patients qualitatively differs from that of their SLE counterparts in terms of target genes and transcription factors binding sites, and, remarkably, genomic imprints found in RA patients were more heterogeneous (48).